These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 426510

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of cefamandole in patients with normal and impaired renal function.
    Mellin HE, Welling PG, Madsen PO.
    Antimicrob Agents Chemother; 1977 Feb; 11(2):262-6. PubMed ID: 848932
    [Abstract] [Full Text] [Related]

  • 5. Cefamandole kinetics in uremic patients undergoing hemodialysis.
    Gambertoglio JG, Aziz NS, Lin ET, Grausz H, Naughton JL, Benet LZ.
    Clin Pharmacol Ther; 1979 Nov; 26(5):592-9. PubMed ID: 498702
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of ceforanide in patients with end stage renal disease on hemodialysis.
    Hess JR, Berman SJ, Boughton WH, Sugihara JG, Musgrave JE, Wong EG, Siemsen AM.
    Antimicrob Agents Chemother; 1980 Feb; 17(2):251-3. PubMed ID: 7387145
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of cefamandole in rabbits with experimentally induced renal impairment.
    Campillo JA, Dominguez-Gil AA, Cepeda M, Dominguez-Gil A.
    J Antibiot (Tokyo); 1980 Mar; 33(3):322-7. PubMed ID: 7380743
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative pharmacokinetics of cefoperazone and cefamandole.
    Srinivasan S, Francke EL, Neu HC.
    Antimicrob Agents Chemother; 1981 Feb; 19(2):298-301. PubMed ID: 6214988
    [Abstract] [Full Text] [Related]

  • 12. Disposition kinetics of cefamandole during continuous ambulatory peritoneal dialysis.
    Bliss M, Mayersohn M, Arnold T, Logan J, Michael UF, Jones W.
    Antimicrob Agents Chemother; 1986 Apr; 29(4):649-53. PubMed ID: 3707113
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Ceforanide kinetics in renal insufficiency.
    Hawkins SS, Alford RH, Stone WJ, Smyth RD, Pfeffer M.
    Clin Pharmacol Ther; 1981 Oct; 30(4):468-74. PubMed ID: 7285481
    [Abstract] [Full Text] [Related]

  • 15. Cefonicid kinetics in subjects with normal and impaired renal function.
    Blair AD, Maxwell BM, Forland SC, Jacob L, Cutler RE.
    Clin Pharmacol Ther; 1984 Jun; 35(6):798-803. PubMed ID: 6734031
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds.
    Neu HC.
    J Infect Dis; 1978 May; 137 Suppl():S80-S87. PubMed ID: 650006
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of cephalosporins in patients with normal or reduced renal function.
    Andriole VT.
    J Infect Dis; 1978 May; 137 Suppl():S88-S99. PubMed ID: 349098
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. An overview of pharmacokinetics.
    Cutler RE.
    Rev Infect Dis; 1984 May; 6 Suppl 4():S803-8. PubMed ID: 6522921
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.